CL
Connie Lam
Institute of Clinical Pathology and Medical Research, UNSW Sydney
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Tuberculosis Research and Epidemiology
0000-0003-0998-5400
Employment
-
Institute of Clinical Pathology and Medical Research Genomic Epidemiologist2019 - Present
Education
- 2009 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (23)
- Examining wealth-related inequality in childhood vaccination in Fiji using the UNICEF Multiple Indicator Cluster Survey 2021 Save
- Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine Save
- Respiratory virus genomic epidemiology during post-pandemic re-emergence of influenza in Australia Save
- Genomic characteristics of prospectively sequenced Mycobacterium tuberculosis from respiratory and non-respiratory sources Save
- Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review Save
- A laboratory framework for ongoing optimization of amplification-based genomic surveillance programs Save
- Exploring programmatic indicators of tuberculosis control that incorporate routine Mycobacterium tuberculosis sequencing in low incidence settings: a comprehensive (2017–2021) patient cohort analysis Save
- Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants Save
- Genomic evolution of SARS-CoV-2 variants of concern underin vitroneutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine Save
- SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture Save
- Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine Save
- Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection Save
- Documenting elimination of co-circulating COVID-19 clusters using genomics in New South Wales, Australia Save
- Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose Save
- SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities to Detect Variants from Low-Viral-Load Samples Save
- World Tuberculosis Day 2021 Theme — ‘The Clock is Ticking’ — and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic Save
- Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling Save
- Investigating genome reduction of Bordetella pertussis using a multiplex PCR-based reverse line blot assay (mPCR/RLB) Save
- Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia Save
- Population Structure and Evolution of Non-O1/Non-O139 Vibrio cholerae by Multilocus Sequence Typing Save